Recurarization after sugammadex reversal in an obese patient

Canadian Journal of Anesthesia

Volumn 58, Issue 10, 2011, Pages 944-947

  Le Corre, Frédérique ^a   Nejmeddine, Salmi ^a   Fatahine, Chérif ^a   Tayar, Claude ^a   Marty, Jean ^a   Plaud, Benoît ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CURARE; DEXAMETHASONE; IRBESARTAN; ROCURONIUM; SUGAMMADEX;

ADULT; ARTICLE; BRADYPNEA; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG TOLERABILITY; ENDOTRACHEAL INTUBATION; FEMALE; GASTRECTOMY; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MUSCLE EXCITATION; MUSCLE RELAXATION; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY FAILURE; SLEEP APNEA SYNDROME; SURGICAL INFECTION; TUBE REMOVAL; WOUND DEHISCENCE;

ANDROSTANOLS; ANESTHESIA, GENERAL; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; INTUBATION, INTRATRACHEAL; LAPAROSCOPY; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; OBESITY; RESPIRATORY INSUFFICIENCY; SURGICAL WOUND DEHISCENCE;

EID: 80755139590     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-011-9554-y     Document Type: Article

References (19)

1. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-22.
2. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27: 874-81.
3. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gomez JA. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine, a multicenter, randomized, controlled trial. Anesth Analg 2010; 110: 64-73.
4. Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuroniuminduced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007; 104: 582-4.
5. Drobnik L, Sparr HJ, Thorn SE, et al. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex. Eur J Anaesthesiol 2010; 27: 866-73.
6. Fuchs-Buder T. Less is not always more: sugammadex and the risk of under-dosing. Eur J Anaesthesiol 2010; 27: 849-50.
7. Dahaba AA, von Klobucar F, Rehak PH, List WF. The neuromuscular transmission module versus the relaxometer mechanomyograph for neuromuscular block monitoring. Anesth Analg 2002; 94: 591-6. (Pubitemid 34177555)
8. Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium- induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104: 563-8.
9. Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol 2003; 20: 467-9. (Pubitemid 36648171)
10. Hemmerling TM, Donati F. The M-NMT mechanosensor cannot be considered as a reliable clinical neuromuscular monitor in daily anesthesia practice. Anesth Analg 2002; 95: 1826-7. (Pubitemid 35424002)
11. Kopman AF. Is the Datex-Ohmeda M-NMT module a research quality instrument? Eur J Anaesthesiol 2004; 21: 833-4. (Pubitemid 40288247)
12. Haute Autorité de Santé. Commission de la transparence. Avis du 21 janvier 2009. Available from URL: http://www.has-sante.fr/ portail/upload/docs/application/pdf/2009-02/bridion-ct-6014. pdf (accessed February 2011).
13. Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104: 31-9.
14. Meyhoff CS, Lund J, Jenstrup MT, et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg 2009; 109: 787-92.
15. Illman HL, Laurila P, Antila H, Meretaja OA, Alahuhta S, Olkkola KT. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. Anesth Analg 2011; 112: 63-8.
16. Plaud B. Sugammadex: something new to improve patient safety or simply a gadget? (French). Ann Fr Anesth Reanim 2009; 28: S64-9.
17. Kopman AF. Managing neuromuscular block: where are the guidelines? Anesth Analg 2010; 111: 9-10.
18. Miller RD, Ward TA. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Anesth Analg 2010; 111: 3-5.
19. Viby-Mogensen J, Claudius C. Evidence-based management of neuromuscular block. Anesth Analg 2010; 111: 1-2.